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Activated Forkhead Transcription Factor Inhibits
Neointimal Hyperplasia After Angioplasty Through
Induction of p27
Kyung-Woo Park, Dae-Hee Kim, Hyun-Jung You, Jung-Ju Sir, Soo-In Jeon, Seock-Won Youn,
Han-Mo Yang, Carsten Skurk, Young-Bae Park, Kenneth Walsh, Hyo-Soo Kim
Objective—We examined the effects of FKHRL1 (forkhead transcription factor in rhabdomyosarcoma like-1) overexpres-
sion on vascular smooth muscle cell (VSMC) proliferation, apoptosis, and cell cycle, in vitro, and the role of FKHRL1
and p27 in the pathophysiology of neointimal growth after balloon angioplasty, in vivo. Furthermore, we tested whether
FKHRL1 overexpression can inhibit neointimal hyperplasia in a rat carotid artery model.
Methods and Results—Adenovirus expressing the constitutively active FKHRL1 (FKHRL1-TM; triple mutant) with 3 Akt
phosphorylation sites mutated was transfected to subconfluent VSMCs. FKHRL1 overexpression in cultured VSMCs
increased p27 expression, leading to G1 phase cell-cycle arrest and increased apoptosis. In vivo, the phosphorylation of
FKHRL1 increased significantly 3 hours after balloon injury and decreased thereafter, with the subsequent downregu-
lation of p27. Although the phosphorylation of FKHRL1 was greatest at 3 hours, the downregulation of p27 showed a
temporal delay, only slightly starting to decrease after 3 hours and reaching a nadir at 72 hours after balloon injury. Gene
transfer of FKHRL1-TM increased p27, decreased proliferation, and increased apoptosis of VSMCs, which resulted in
a marked reduction in neointima formation (intima-to-media ratio: 0.310.13 versus 1.170.28, for FKHRL1-TM
versus Adv-GFP; P0.001).
Conclusion—Balloon angioplasty leads to the phosphorylation of FKHRL1 and decreased expression of p27, thereby
promoting a proliferative phenotype in VSMCs in vitro and in vivo. This study reveals the importance of FKHRL1 in
proliferation and viability of VSMCs and suggests that it may serve as a molecular target for interventions to reduce
neointima formation after angioplasty. (Arterioscler Thromb Vasc Biol. 2005;25:742-747.)
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Despite the recent advances in strategies to preventneointimal growth after angioplasty, it still remains the
major limitation of percutaneous coronary interventions.1
Although the pathogenic mechanism of restenosis is complex,
the proliferation and migration of vascular smooth muscle
cells (VSMCs) after balloon injury seems to be a major factor
in this process.2–4 Therefore, we along with many investiga-
tors have targeted VSMC proliferation and migration as a
means to counter restenosis.5,6
FKHRL1 (forkhead transcription factor in rhabdo-
myosarcoma-like 1, FOXO3a) is a member of the forkhead
transcription factor family, which is emerging as a key factor
in pathways that regulate differentiation, metabolism, prolif-
eration, and survival of cells.7 FKHRL1 is negatively regu-
lated by the PI3K/Akt pathway.8–10 Phosphorylation of
FKHRL1 by Akt leads to cytoplasmic retention and impair-
ment of its nuclear transcriptional activity. Past studies have
shown that the key actions of forkhead family transcription
factors are cell-cycle arrest11–14 and apoptosis.9
Taken together, FHKRL1 may affect the cell cycle and
apoptosis of VSMCs, and may serve as a therapeutic target to
inhibit neointimal growth after angioplasty. In the present
study, we examined the effects of FKHRL1 on VSMC
survival and proliferation in vitro. We also investigated
whether FKHRL1 plays a role in neointima formation after
balloon injury, and we tested whether the cytotoxic and
cytostatic properties FKHRL1 can reduce neointimal hyper-
plasia after balloon injury in a rat carotid injury model.
Materials and Methods
Construction of Adenoviral Vectors Expressing
Constitutively Active Triple Mutant
Detailed preparation procedures were previously described.11 The
hemagglutinin-tagged human FKHRL1 triple mutant (TM: T32A/
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S253A/S315A) and wild-type sequence cDNA were subcloned into
a shuttle vector pAdTrack–cytomegalovirus, which contains green
fluorescent protein (GFP) under the control of a separate cytomeg-
alovirus promoter. The FKHRL1-AAA triple mutant (FKHRL1-TM)
is not phosphorylatable because 3 phosphorylation sites, Thr32,
Ser253, and Ser315, were replaced by alanine residues. For experi-
ments with these reagents, control cultures were infected with an
adenoviral vector expressing only the GFP transgene (Ad-GFP)
prepared by the same system.
Cell Culture
Cells were incubated at 37°C in Dulbecco modified Eagle medium
containing 10% fetal bovine serum with penicillin/streptomycin.
Primary cultures of rat smooth muscle cells were prepared from
thoracic aortas of adult male Sprague–Dawley rats according to
Mader et al.12 For all experiments, rat aortic SMCs from passages 6
to 7 were used. SMCs were grown to 70% to 80% confluence and
then made quiescent by incubation with Dulbecco modified Eagle
medium containing 0.1% fetal bovine serum for 48 hours
Cell Viability Assays
Cell viability was determined by WST-1 assay (Roche) as suggested
by the manufacturer. Soon after, VSMCs were seeded in 96-well
plates and infected with the indicated adenoviral vectors. At 24 and
48 hours after infection, 10 L Cell Proliferation Reagent WST-1
was added and incubated for 4 hours at 37°C. Absorbency was
measured using an enzyme-linked immunosorbent assay reader at
440 nm
FKHRL1 and Apoptosis
Subconfluent rat VSMCs were infected with adenoviruses (Adv-
FKHRL1-TM and Adv-GFP, respectively) at 50 multiplicities of
infection (moi) for 48 hours, harvested with trypsin, fixed in cold
90% ethanol for 20 minutes, and then resuspended in staining buffer
consisting of 1 mg/mL RNaseA, 20 g/mL propidium iodide, and
0.01% NP40. DNA content was analyzed by flow cytometry on FL-2
channel and gating was set to exclude debris and cellular aggregates.
For each analysis, 10 000 events were counted.
FKHRL1 and Cell-Cycle Regulation
To test the effect of FKHRL1 on cell cycle, rat VSMCs were starved
without serum and simultaneously infected with adenoviruses, Adv-
FKHRL1-TM and Adv-GFP respectively, at 50 moi for 24 hours,
and stimulated with 20% fetal bovine serum for 24 hours. After
serum stimulation, cells were trypsinized, centrifuged at 1200 rpm
for 5 minutes, washed with phosphate-buffered saline, and treated
with RNase A (20 g/mL). DNA was stained with propidium iodide
(100 g/mL) for 30 minutes at 4°C in the dark. DNA content of the
cells was analyzed using a Becton Dickinson fluorescence-activated
cell sorter Calibur flow cytometer (Becton Dickinson, San Jose,
Calif). DNA histogram analysis was performed using ModFitLT
software (Becton Dickinson). The percentage of each cell cycle
phase was compared between 2 groups.
Immunoblot Assay
Cells were infected with adenoviral vector (Adv-FKHRL1-TM or
Adv-GFP) at 50 moi for 20 hours. Cells were washed in phosphate-
buffered saline and harvested by scraping in 50 mmol/L Tris-HCl
(pH 7.2), 250 mmol/L NaCl, 1% NP40, 0.05% SDS, 2 mmol/L
EDTA, 0.5% deoxycholic acid, 10 mmol/L glycerophosphate, and
1 mmol/L phenyl methyl sulfonyl fluoride. The primary antibodies
used were anti-total FKHRL1 antibody (1:500 dilution; Upstate
Biotechnology), anti-HA (hemagglutinin; 1:4000; Roche), and anti-
p27 (1:1000; BD Transduction Laboratories).
Measurements of phospho-FKHRL1 and p27 in
Carotid Arteries After Balloon Injury
A previously well-established rat carotid artery balloon injury model
was used.5 The vessel was harvested at several serial points after
balloon injury (3 hours, 24 hours, 72 hours, and 2 weeks) to examine
the endogenous change in FKHRL1 phosphorylation and p27 ex-
pression. Western blot analysis of vessel protein lysates using
anti-phospho-FKHRL1 antibody (1:100; Upstate Biotechnologies)
and anti-p27 antibody (1:100; Santa Cruz) were performed. The
serial change in the expression of phopho-FKHRL1 and p27 were
also confirmed by immunohistochemistry using phospho-FKHRL1
antibody (1:50; Upstate Biotechnologies) and anti-p27 antibody
(1:50; Santa Cruz).
Adenoviral Vector-Mediated Gene Delivery After
Rat Carotid Artery Balloon Denudation Injury
An adenoviral vector, expressing either the nonphosphorylatable,
constitutively active of FKHRLl (FKHRL1-TM), or the control gene,
GFP, were used for gene delivery. Forty-three adult male Sprague–
Dawley rats weighing from 400 to 500 grams (Daehan Biolink Co)
were anesthetized with a combination anesthetic (ketamine, 70
mg/kg; xylazine, 7 mg/kg intraperitoneal; Yuhan Corp, Bayer,
Korea). The balloon injury was performed in a common carotid
artery by 2-French catheter as previously described.5 After balloon
injury, viral infusion mixtures with 5108 pfu of virus containing
either constitutively active FKHRL1 gene (Adv-FKHRL1-TM) or
control gene (Adv-GFP) diluted to a total volume of 100 L were
instilled into the arterial segment that was isolated by vascular
clamps and incubated for 30 minutes.
Morphometric Analysis
The vessels of rats were harvested on days 3 and 14 after balloon
injury as previously described.5 The tissues were then embedded in
paraffin, and sections were stained with hematoxylin and eosin or
elastica van Gieson. The extent of neointimal formation was quan-
tified by computed planimetry of histologically stained sections. The
cross-sectional areas of the blood vessel layers including the lumen
area, intimal area, and medial area were quantified at 3 different
sections (proximal, middle, and distal, n10) by using Image Pro
Plus Analyzer Version 4.5 (Media Cybernetics). The intima-to-
media ratios were calculated from the mean of these determinations.
In addition, the number of nucleated cells in the media was counted
at day 3 after balloon injury from 4 different high-power fields per
sample at 3 levels (n8).
Immunohistochemical Staining
To detect proliferating cells, immunohistochemical staining against
proliferating cell nuclear antigen (PCNA) were performed on the
virus-treated arteries.5 Proliferation was assessed by quantifying the
percentage of PCNA-positive cells against total nucleated cells in 4
different sectors per tissue section (n8). Apoptotic cells were
confirmed by treating specimens with 1:200 diluted cleaved
caspase-3 antibody (Cell Signaling Technology) in a similar manner.
The transduction efficiency was determined as the percentage of
hemagglutinin (which was tagged to the adenoviral vector) stained
versus total medial and neointimal cells per arterial section. The
calculations were performed from 4 different high-power fields per
sample, which were cut at 3 different levels of the carotid artery
(n8).
Double Immunohistochemical Staining
For double-staining we used an EnVision Doublestain kit (DakoCy-
tomation) according to the manufacturer’s instructions. Briefly, the
first part of the 2-part procedure was performed using primary
antibody (anti- smooth muscle actin antibody, 1:100; DAKO),
peroxidase-labeled polymer, and liquid DAB. After initial staining
with liquid DAB, a double-staining block was added to the slides for
3 minutes. Then, the second part of the procedure was performed
using primary antibody (anti-HA antibody, 1:250; Santa Cruz; or
anti-caspase-3 antibody, 1:100; Cell Signaling Technology), alkaline
phosphatase-labeled polymer, and fast red. After fast red staining,
hematoxylin (DAKO) counterstaining was performed.
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Terminal Deoxynucleotidyl Transferase-Mediated
dUTP Nick End-Labeling Staining
Detection of apoptotic cells in vivo was also performed using the
terminal deoxynucleotidyl transferase-mediated dUTP nick end-
labeling (TUNEL)13 method with minor modifications. Apoptotic
cells were quantified by counting the percentage of TUNEL-positive
cells against total nucleated cells in 4 different sectors per tissue
section (n8).
Statistical Analysis
All data were presented as meanSD. Comparisons between con-
stitutively active FKHRL1 transfected and control group were
performed using an unpaired 2-tailed t test, but the comparison of
results from in vitro studies were performed using Mann–Whitney U
test because of small numbers. Values of P0.05 were considered
significant. SPSS 11.0 software was used for all statistical
calculations.
Results
FKHRL1 Overexpression Induces p27 Expression
in Cultured VSMCs
Efficient transfection of constitutively active FKHRL1-TM gene
was confirmed by detecting the expression of hemagglutinin,
which was tagged onto the viral construct, as shown by Western
blot analysis (Figure 1A; cells harvested 24 hours after gene
delivery). The overexpression of FKHRL1-TM increased the
expression of p27 compared with control. In addition, we
confirmed the existence of endogenous FKHRL1 expression in
rat VSMCs using anti-FKHRL1 Ab (Figure 1A).
FKHRL1 Overexpression Decreases VSMC
Viability: Effect of Cell-Cycle Arrest and Apoptosis
To investigate the effect of FKHRL1 overexpression on
VSMC viability, serum-stimulated (fetal bovine serum 10%)
rat VSMC cultures were transfected with either Adv-GFP or
Adv-FKHRL1-TM at 50 moi, which results in 95% trans-
fection efficiency. Cell viability was measured 24 and 48
hours after gene transfer using WST-1 assay. Overexpression
of FKHRL1 significantly diminished cell viability at both
time points (Figure 1B; P0.01, at both 24 and 48 hours).
Cell-cycle analysis using fluorescence-activated cell sorter
(Figure 1C) showed that the percentage of cells in the G1
phase was significantly greater (52.30.04 versus
69.00.04%, n4; P0.02) and the percentage of cells in
the S phase was significantly lower (33.90.03 versus
14.60.01%, n4; P0.02) in FKHRL1-TM–transfected
VSMCs compared with GFP-transfected VSMCs. Thus, the
G1/S ratio was significantly greater in the FKHRL1-TM
group, consistent with cell-cycle arrest of the G0/G1 phase.
To assess the effect of FKHRL1 overexpression on VSMC
apoptosis, fluorescence-activated cell sorter analysis of apo-
ptotic bodies with hypodiploid DNA was performed. Adv-
FKHRL1-TM gene transfer resulted in significantly increased
subdiploid fraction (sub G1 peak) compared with GFP,
confirming increased apoptosis. Under fluorescent micros-
copy, FKHRL1-TM gene transfer significantly increased
floating dead cells with condensed and fragmented nuclei
compared with GFP control at 48 hours (Figure 1D).
Forkhead Transcription Factor Is Phosphorylated
Immediately After In Vivo Balloon Injury
From the in vitro data, we concluded that the overexpression of
FKHRL1 leads to VSMC apoptosis and cell-cycle arrest. Be-
cause the proliferation of VSMCs after balloon injury is an
important mechanism of neointima formation after angioplasty,
we hypothesized that overexpression of FKHRL1 might reduce
neointima formation. Before testing this hypothesis, we exam-
ined the endogenous expression of FKHRL1 and its downstream
effecter molecule, p27, after balloon injury. Western blot of in
vivo vessel samples at various time points showed that phos-
phorylation of FKHRL1 resulting in its inactivation occurs as
soon as 3 hours after balloon injury, decreases at 24 hours, and
then returns to baseline levels by day 3. The expression of p27,
which we expected to be downregulated by phosphorylation of
FKHRL1, showed a temporal delay in comparison to its up-
stream transcription factor FKHRL1. Compared with phospho-
FKHRL1, which was markedly increased at 3 hours, the expres-
sion of p27 was similar to baseline up to 3 hours after injury,
slowly declining to its lowest expression at day 3 (Figure 2A).
The changes observed with Western blot samples were well-
correlated with the immunohistochemistry results of phospho-
FKHRL1 (Figure 2B) and p27 (Figure 2C).
Constitutively Active FKHRL1-TM Gene Transfer
Increases p27 and Inhibits Neointima Formation
After Balloon Injury
To examine the effect of FKHRL1 overexpression on neoin-
timal formation after angioplasty, we delivered adenoviral
vectors containing constitutively active FKHRL1-TM to
balloon-injured rat carotid arteries. Successful gene transfer
of FKHRL1 was confirmed in the vasculature by detecting
the hemagglutinin tag using Western blot analysis. The gene
transduction efficiency, which was measured as the percent-
Figure 1. Effect of constitutively active FKHRL1-TM gene trans-
fer on VSMCs in vitro. A, Immunoblot analysis of harvested cells
24 hours after gene delivery. B, WST-1 assays performed at 24
and 48 hours after gene transfer to cultured VSMCs in Dulbecco
modified Eagle medium with fetal bovine serum 10% showing
significant decrease in cell viability after overexpression of
FKHRL1 (*P0.01). C, Fluorescence-activated cell sorter analy-
sis of the cell cycle showing a typical profile of G0/G1 cell-cycle
arrest in the FKHRL1 group. D, Increased apoptosis after
FKHRL1 overexpression as examined by fluorescence-activated
cell sorter analysis and fluorescent microscopy. The construct of
adeno-FKHRL1 also contains the GFP gene.
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age of hemagglutinin (which was tagged to the adenoviral
vector) stained versus total medial and neointimal cells per
arterial section, was 38.6%10.7% (n8). In the control
GFP group, the expression of p27 was low at day 3 and
increased thereafter at day 14. However, the gene transfer of
constitutively active FKHRL1 resulted in a significant in-
crease in p27 expression compared with GFP at day 3.
Although the expression of hemagglutinin was faint at week
2, the higher expression of p27 in the FKHRL1-TM group
was sustained (Figure 3A). Immunoprecipitation Western
blotting of total FKHRL1 showed that endogenous total
FKHRL1 expression did not change after balloon injury and
was only significantly increased after FKHRL1-TM gene
transfer (Figure IA, available online at http://atvb.ahajournal-
s.org). Furthermore, the cells transduced with the adenoviral
vectors were confirmed as medial smooth muscle cells by
double immunohistochemical staining (Figure IB). Morpho-
metric analysis 14 days after gene delivery revealed that the
overexpression of the constitutively active FKHRL1 gene
resulted in a significantly reduced neointimal area
(0.160.03 versus 0.050.03 mm2; P0.01), whereas there
was no significant difference in medial area (0.170.03
versus 0.160.03 mm2; P0.34) compared with the GFP-
transfected group (Figure 3B and 3C). Although there were
no significant differences in medial area, the cellularity of the
media was significantly lower in the FKHRL1-TM–trans-
fected group at day 3 (42.45.3 versus 28.96.1 cells/high-
power field, for control versus FKHRL1-TM, n8; P0.01).
This led to a significantly lower intima-to-media ratio
(0.960.19 versus 0.350.17; P0.01) and a greater lumen
area (0.270.04 versus 0.350.06 mm2; P0.01) compared
with the GFP-transfected group (Figure 3B and 3C).
Constitutively Active FKHRL1-TM Gene Transfer
Inhibits Proliferation and Increases Apoptosis of
VSMCs After Balloon Injury
Immunohistochemical staining for PCNA was performed to
examine the effects of the constitutively active FKHRL1 gene
transfer on VSMC proliferation during neointimal formation
after balloon injury. PCNA-positive cells were markedly re-
duced in the FKHRL1-TM transfected group (Figure 4A). The
proliferative index (calculated as the fraction of positive cells
among total nucleated cells) was significantly lower in the
FKHRL1-TM gene-transfected group at both 3 days (0.380.05
versus 0.280.05, n8, P0.001 for GFP versus FKHRL1-
TM) and 2 weeks (0.080.19 versus 0.060.01, n8, P0.02
for GFP versus FKHRL1-TM) after gene delivery (Figure 4B).
Figure 2. Endogenous serial expression of phospho-FKHRL1 and
p27 after balloon injury. A, Western blot showing serial change in
expression of phospho-FKHRL1 and p27 in vessel samples after
balloon injury. The response of p27 expression, which is down-
stream of FKHRL1, shows a temporal delay compared with
phospho-FKHRL1. B and C, Corresponding immunohistochemistry
of phospho-FKHRL1 and p27. Note that staining is limited to the
cytoplasm showing inhibited nuclear translocation of FKHRL1.
Figure 3. Effect of FKHRL1-TM gene transfer on neointima forma-
tion after balloon injury. A, Western blot confirming efficient delivery
of the FKHRL1-TM transgene and increased expression of p27 at
days 3 and 14. The expression of p27 is greatly increased by
FKHRL-TM gene transfer at day 3 compared with the control
group. Although p27 expression was increased in the GFP group
at 2 weeks compared with day 3, the FKHRL1-TM group still main-
tained higher p27 expression at 2 weeks compared with the GFP
control group. B, Hematoxylin and eosin and Elastica van Gieson
(in set) staining of artery at 14 days after balloon injury. C, Mor-
phometry at 14 days after gene delivery.
Figure 4. Effect of FKHRL1-TM gene transfer on VSMC prolifer-
ation and apoptosis after balloon injury. A, Immunohistochemi-
cal staining against PCNA at days 3 and 14 and TUNEL staining
at day 3 showing markedly reduced PCNA-positive cells at both
time points and increased apoptotic cells in the active FKHRL1-
transfected group. B, Proliferative index. C, Apoptotic activity
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To determine the effect of constitutively active FKHRL1 gene
transfer on apoptosis after balloon injury in vivo, TUNEL
staining (Figure 4A) and immunohistochemistry for active and
cleaved caspase-3 (Figure IIA, available online at http://atvb.
ahajournals.org) was performed at 3 days after balloon injury.
The apoptotic activity of VSMCs was high in the GFP-
transfected and FKHRL1-TM–transfected group, although apo-
ptotic activity was higher in the FKHRL1-TM–transfected group
(27.95.88 versus 46.54.05%, n8, P0.001 for GFP versus
FKHRL1-TM). Even at 2 weeks after balloon injury, when the
apoptotic activity declined considerably, the apoptotic activity
remained significantly higher in the FKHRL1-TM–transfected
group compared with the GFP-transfected group (7.31.11%
versus 10.91.78%, n8, P0.001 for GFP versus FKHRL1-
TM) (Figure 4C). Furthermore, double immunohistochemistry
showed that the cells undergoing apoptosis and thus positive for
caspase 3 are smooth muscle cells (Figure IIB).
Discussion
The process of neointima formation after balloon injury is
complex, and elucidation of possible key molecules involved in
the pathophysiology of neointimal hyperplasia may help in the
efforts to reduce restenosis. In the present study, we report for
the first time to our knowledge that FKHRL1 and p27 play an
important role in the response to balloon denudation injury and
neointima formation in rats. In vitro, the overexpression of
FKHRL1 by constitutively active FKHRL1-TM gene transfer
resulted in increased apoptosis, induction of p27, and G1/S
phase cell-cycle arrest of cultured VSMCs. In vivo, carotid
balloon injury resulted in phosphorylation of FKHRL1, which
led to temporally delayed p27 downregulation and neointimal
formation in rat carotid arteries. The importance of FKHRL1
and p27 were confirmed by constitutively active FKHRL1 gene
transfer, which increased p27 expression and resulted in de-
creased neointimal hyperplasia after angioplasty.
FKHRL1 (forkhead transcription factor in rhabdomyosar-
coma like 1, FOXO3a) is a member of the forkhead transcription
factor family, which has been shown to play an important role in
cell-cycle arrest and apoptosis of various cells. In various cancer
cell lines,14,15 endothelial cells,16 and VSMCs,17 forkhead tran-
scription factors have been shown to induce G1 phase cell-cycle
arrest. Recently, several studies demonstrated the regulation of
p27 by forkhead transcription factors. Forkhead transcription
factors were shown to mediate cell-cycle regulation by PKB
through p27 but not p21 in cancer cell lines,14,15 and the
inhibition of FKHRL1 was reported to promote endothelial
proliferation by downregulation of p27 in human endothelial
cells.16 In VSMCs, inactivation of forkhead transcription factors
by mechanical strain resulted in transcriptional downregulation
of p27.17
In addition, FHKRL1 has been shown to induce apoptosis in
neuronal cell lines and fibroblasts by upregulation of Fas-ligand
expression and activation of the death receptor pathway.9 How-
ever, in hematopoietic cells, the “intrinsic” mitochondrial path-
way, rather than the “extrinsic” Fas-mediated pathway, was
shown to promote apoptotic cell death after activation of
FKHRL1 signaling.18 In VSMCs, we previously showed that
FKHRL1 activates caspase 9, caspase 3, and c-Jun sequentially,
and induces FasL to result in apoptosis under conditions of
cellular stress.19 In the present study, overexpression of
FKHRL1 resulted in increased expression of p27 and decreased
survival of cultured VSMCs, which was caused by increased
apoptosis and cell-cycle arrest. Constitutively active FKHRL1
gene transfer resulted in a marked increase in apoptosis and a
typical profile of G0/G1 phase cell-cycle arrest (increase in cells
in G1 phase and decrease in cells in S phase).
The p27kip1 is a cyclin-dependent protein kinase (CDK)
inhibitor, which regulates the cell cycle via downregulation of
CDK2 activity and repression of cyclin A transcription.20 CDK/
cyclin holoenzymes facilitate the progression of the cell cycle
and is negatively regulated by the interaction with specific CDK
inhibitory proteins that cause cell-cycle arrest when overex-
pressed in transformed and nontransformed cell lines.21–23 Mice
lacking the CDK inhibitor function of p27 display enhanced
growth and multiple organ hyperplasia24 and overexpression of
p27 in rat carotid arteries attenuated neointimal hyperplasia.25 In
past studies, it has been shown that p27 expression is induced
after balloon injury. In addition, the importance of p27 in
regulating neointimal hyperplasia is well-documented by a
previous study, which demonstrated that p27 gene transfer
attenuates neointimal hyperplasia,26 and by the success of
rapamycin-coated stent in reducing restenosis after coronary
angioplasty.27
The sequential change in expression levels of p27 after
vessel injury seems to be somewhat different among different
species. Reis et al reported that p27 began to increase 48
hours after balloon injury and persisted through the fourth
week in mouse femoral artery injury model,28 whereas in rat
carotid arteries, p27 was already increased at 48 hours after
balloon injury.26 In porcine artery injury model, p27 began to
decrease after balloon injury, stayed at the bottom level from
day 4 to day 14, and then began to increase.29 In the present
study, we found that there is a temporal delay between the
phosphorylation of FKHRL1 and the consequent downregu-
lation in p27 expression. Compared with FKHRL1 phosphor-
ylation, which is strongest at 3 hours after injury and declines
to undetectable baseline levels by day 14, p27 expression
only starts to decline slightly at 3 hours after balloon injury
and reaches nadir at 72 hours, finally to be strongly re-
expressed at day 14. The increase from baseline and decrease
thereafter of phospho-FKHRL1 coincides with the downregu-
lation from baseline and upregulation thereafter of p27 except
with a temporal delay. This sequential change is concordant
with previous cell kinetic studies which showed that VSMC
proliferation and migration starts early after vessel injury, is
greatest at 72 hours, and slowly declines to baseline levels
by 2 weeks. Furthermore, we found that the gene transfer of
constitutively active FKHRL1 results in upregulation of p27
and significant inhibition of neointimal proliferation after
angioplasty, suggesting the importance of FKHRL1 phos-
phorylation and consequent downregulation of p27 in neoin-
tima formation. This is a novel finding that may have
implications in future research. In the FKHRL1-TM gene
transfer group, FKHRL1-TM was strongly expressed at day
3, whereas only faintly expressed at 2 weeks. Expression of
p27, however, was moderate at day 3 and strong at 2 weeks,
although its expression at each time point (3 days and 2
weeks) was significantly greater in the FKHRL1-TM group
746 Arterioscler Thromb Vasc Biol. April 2005
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than that of the control group. The disparity is probably
because of the fact that after adenovirus-mediated gene
transfer, the expression of the adenoviral transgene is highly
expressed at 3 days and declines markedly to low levels by 2
to 3 weeks.30,31 Considering also that a significant portion of
the gene-transfected smooth muscle cells underwent apopto-
sis, the faint expression of FKHRL1-TM at 2 weeks is not
surprising. The high expression of p27, however, was more
because of the endogenous restoration of p27 expression in
VSMCs, as we showed in Figure 2A. As seen in Figure 2A,
the rebound expression of p27 at 2 weeks after injury is even
stronger than at baseline levels.
In conclusion, balloon angioplasty leads to the phosphor-
ylation of FKHRL1 and downregulation of p27 resulting in a
proliferative phenotype in VSMCs. FKHRL1 overexpression
increases p27 expression, leading to G1/S phase cell-cycle
arrest and increased apoptosis of VSMCs, thereby inhibiting
neointimal hyperplasia. This study reveals the importance of
FKHRL1 in proliferation and viability of VSMCs and sug-
gests that it may serve as a target for interventions to inhibit
neointima formation after angioplasty.
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